Summary
Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.
Related bills
Legislative Journey
- Introduced
- Committee
- Floor
- Passed Chamber 1
- Passed Chamber 2
- Signed
Jan 9, 2025
REFERRED TO INSURANCE
HouseJan 7, 2026
REFERRED TO INSURANCE
HouseMar 18, 2026
REPORTED
HouseMar 19, 2026
ADVANCED TO THIRD READING CAL.311
House